Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Trump’s Department of War bets $47M on Flagship biotechs to develop countermeasures

Trump’s Department of War bets $47M on Flagship biotechs to develop countermeasures

September 23, 2026Posted inBiotechnology

The Department of War has awarded Flagship Pioneering $47 million to develop medical countermeasure technologies against emerging threats.

Post navigation

Previous Post
Enveda reaps $311M series E to feed ambition to become a ‘household name’
Next Post
New Immune Checkpoint Discovery Explains Why Gastric Cancers Ignore PD-1 Drugs new-immune-checkpoint-discovery-explains-why-gastric-cancers-ignore-pd-1-drugs

Recent Posts

  • Four-Year-Old Receives China’s Youngest Documented Leadless Pacemaker Implantation
  • Questionnaire Layout Associated With Response Patterns in Orthopaedic Patient Surveys
  • Lower Vitamin D and Magnesium Levels Track Degenerative Temporomandibular Disorders
  • Immune Microenvironment Breakdown at Neuromuscular Junctions Drives Early Sarcopenia
  • LoRA-BERT Accurately Predicts Long Non-Coding RNAs Even From Partial Transcripts

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • September 2024
  • August 2024
  • March 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top